NEJM Review Time

NEJM publishes approximately 350 original articles per year from roughly 5,000-6,000 submissions. The math alone explains the rejection rate. But the editorial criteria are also extremely specific:

The paper must present evidence that could change what a practicing clinician does tomorrow. Not "eventually," not "in principle." The editorial question is: does this result change clinical practice?

Papers that advance understanding without changing practice are desk-rejected. Papers that are clinically interesting but don't have strong enough evidence to change guidelines are desk-rejected. Papers where the clinical consequence is real but narrow (one disease subtype, one demographic) may be redirected to a specialty journal.

NEJM's review process is tighter than most journals:

• Fewer reviewers: Typically 2-3, chosen for clinical and methodological expertise
• Faster turnaround: NEJM asks for 2-week reviewer turnaround and often gets it
• In-house statistical review: Like the Lancet, NEJM has internal statisticians who evaluate methodology
• Focused review criteria: Reviewers assess clinical significance, evidence strength, and whether the paper meets the 2,700-word limit effectively

The review is not a general scientific evaluation. It's specifically about whether the evidence supports a clinical practice change and whether the presentation is appropriate for a physician audience.

Fast desk rejection (1 week): The most common outcome. The paper is good science but not practice-changing evidence. No reflection on quality.

Desk rejection with suggestion (1-2 weeks): The editor may suggest a specialty journal. This means the work has merit but not NEJM-level clinical impact.

Review completed in 4-6 weeks: Typical for papers that enter review. NEJM is efficient once committed.

Revision with 2-week window: Common. NEJM expects revisions to be fast because the data should already exist. New experiments are rarely requested.

Submit if:

• the study presents evidence that could change clinical practice guidelines
• the trial design is a randomized controlled trial, large prospective study, or equivalent quality evidence
• the clinical population is broad enough that practicing physicians worldwide would change their behavior
• the 2,700-word format is appropriate (the study can be communicated concisely)

Think twice if:

• the finding is mechanistic or translational without direct clinical application (Nature Medicine or Science Translational Medicine may be better)
• the clinical importance is real but narrow (JAMA specialty journals may be more appropriate)
• the evidence is observational without a strong enough design to change practice
• the Lancet's global health focus or JAMA's broader clinical scope is a better editorial fit

A free manuscript scan can help assess whether the clinical evidence strength meets NEJM's practice-changing threshold before submission.

How long does NEJM take to desk-reject?

Typically 1-2 weeks. Over 90% of submissions are desk-rejected.

How long does NEJM peer review take?

3-5 weeks for reviewer reports, 4-8 weeks total to first decision.

Why is NEJM faster than the Lancet after the desk?

NEJM has a narrower scope (practice-changing clinical evidence only), which means review criteria are more focused. Reviewers know exactly what to evaluate.

What's the NEJM word limit?

2,700 words for original articles. This is unusually short for a top journal and means the study must be communicated concisely.